Tyra Biosciences, Inc. (TYRA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $77.39M | -15.9% |
| 2024 | $91.97M | +58.5% |
| 2023 | $58.01M | -76.9% |
| 2022 | $251.21M | -16.9% |
| 2021 | $302.18M | +1884.9% |
| 2020 | $15.22M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $77.39M | -15.9% |
| 2024 | $91.97M | +58.5% |
| 2023 | $58.01M | -76.9% |
| 2022 | $251.21M | -16.9% |
| 2021 | $302.18M | +1884.9% |
| 2020 | $15.22M | — |